Nolvadex

Here are some options to consider:

1) Getting financial support for Femara. You may be eligible for financial support to help purchase Femara. One program specifically is the Femara Cares Program at http://femara.com. You may want to ask the community about other financial support programs.
2) Stay on Arimedex and treat the side effects. The medications to treat the side effects may improve your quality of life, but you will need to discuss their costs and side effects with your physician.
3) You may consider the other Aromatase Inhibitor, Aromasin (exemestane). Pfizer has a financial assistance program as well - http://www.pfizerhelpfulanswers.com/pages/misc/Default.aspx
4) Another alternative is Tamoxifen. Studies have shown that Aromatase Inhibitors are more effective in postmenopausal women with ER+ breast cancers, but if side effects are severe, Tamoxifen is an option to consider.

Here are a couple of articles comparing tamoxifen to aromatase inhibitors:
http://www.medscape.com/viewarticle/447550_2
http://www.sciencedaily.com/releases/2008/12/081211161737.htm Here are some options to consider:

1) Getting financial support for Femara. You may be eligible for financial support to help purchase Femara. One program specifically is the Femara Cares Program at http://femara.com. You may want to ask the community about other financial support programs.
2) Stay on Arimedex and treat the side effects. The medications to treat the side effects may improve your quality of life, but you will need to discuss their costs and side effects with your physician.
3) You may consider the other Aromatase Inhibitor, Aromasin (exemestane). Pfizer has a financial assistance program as well - http://www.pfizerhelpfulanswers.com/pages/misc/Default.aspx
4) Another alternative is Tamoxifen. Studies have shown that Aromatase Inhibitors are more effective in postmenopausal women with ER+ breast cancers, but if side effects are severe, Tamoxifen is an option to consider.

Here are a couple of articles comparing tamoxifen to aromatase inhibitors:
http://www.medscape.com/viewarticle/447550_2
http://www.sciencedaily.com/releases/2008/12/081211161737.htm